Short-term bone loss in HIV-infected premenopausal women

Michael T. Yin, Dalian Lu, Serge Cremers, Phyllis C. Tien, Mardge H. Cohen, Qiuhu Shi, Elizabeth Shane, Elizabeth Golub, Kathryn Anastos

Research output: Contribution to journalArticle

Abstract

Background: Low bone mineral density (BMD) has been reported in HIV+ women, but less is known about the longitudinal evolution of BMD and fracture incidence. Methods: In 100 HIV+ and 68 HIV-premenopausal women in the Women's Interagency HIV Study, BMD was measured by dual energy X-ray absorptiometry at the femoral neck (FN) and lumbar spine (LS) at index visit and after a median of 2.5 years. Results: In HIV+ women, BMD at index visit was normal but 5% lower at the LS and FN than in HIV-women. Annual percent decrease in BMD did not differ between HIV+ and HIV-women at the LS (-0.8% ± 0.2% vs-0.4% ± 0.2%, P = 0.20) or FN (-0.8% ± 0.3% vs-0.6% ± 0.3%, P = 0.56) and remained similar after adjustment for age, weight, and BMD at index visit. Among HIV+ women, bone loss was associated with vitamin D deficiency and opiate use but not with use or class of antiretrovirals. Incidence of self-reported fracture was 0.74 per 100 person-years in HIV+ women and similar in HIV-women. Conclusions: In premenopausal HIV+ women, index BMD was lower than comparable HIV-women; however, rates of bone loss at the LS and FN were similar over 2.5 years of observation, irrespective of antiretroviral therapy.

Original languageEnglish (US)
Pages (from-to)202-208
Number of pages7
JournalJournal of Acquired Immune Deficiency Syndromes
Volume53
Issue number2
DOIs
StatePublished - Feb 2010

Fingerprint

HIV
Bone and Bones
Bone Density
Femur Neck
Spine
Opiate Alkaloids
Vitamin D Deficiency
Bone Fractures
Incidence
Photon Absorptiometry
Observation
Weights and Measures

Keywords

  • Bone density
  • Bone loss
  • Bone turnover markers
  • HIV
  • Osteoporosis
  • Premenopausal women

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Yin, M. T., Lu, D., Cremers, S., Tien, P. C., Cohen, M. H., Shi, Q., ... Anastos, K. (2010). Short-term bone loss in HIV-infected premenopausal women. Journal of Acquired Immune Deficiency Syndromes, 53(2), 202-208. https://doi.org/10.1097/QAI.0b013e3181bf6471

Short-term bone loss in HIV-infected premenopausal women. / Yin, Michael T.; Lu, Dalian; Cremers, Serge; Tien, Phyllis C.; Cohen, Mardge H.; Shi, Qiuhu; Shane, Elizabeth; Golub, Elizabeth; Anastos, Kathryn.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 53, No. 2, 02.2010, p. 202-208.

Research output: Contribution to journalArticle

Yin, MT, Lu, D, Cremers, S, Tien, PC, Cohen, MH, Shi, Q, Shane, E, Golub, E & Anastos, K 2010, 'Short-term bone loss in HIV-infected premenopausal women', Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 2, pp. 202-208. https://doi.org/10.1097/QAI.0b013e3181bf6471
Yin, Michael T. ; Lu, Dalian ; Cremers, Serge ; Tien, Phyllis C. ; Cohen, Mardge H. ; Shi, Qiuhu ; Shane, Elizabeth ; Golub, Elizabeth ; Anastos, Kathryn. / Short-term bone loss in HIV-infected premenopausal women. In: Journal of Acquired Immune Deficiency Syndromes. 2010 ; Vol. 53, No. 2. pp. 202-208.
@article{feaec4b699064dc69350cd805598f2a7,
title = "Short-term bone loss in HIV-infected premenopausal women",
abstract = "Background: Low bone mineral density (BMD) has been reported in HIV+ women, but less is known about the longitudinal evolution of BMD and fracture incidence. Methods: In 100 HIV+ and 68 HIV-premenopausal women in the Women's Interagency HIV Study, BMD was measured by dual energy X-ray absorptiometry at the femoral neck (FN) and lumbar spine (LS) at index visit and after a median of 2.5 years. Results: In HIV+ women, BMD at index visit was normal but 5{\%} lower at the LS and FN than in HIV-women. Annual percent decrease in BMD did not differ between HIV+ and HIV-women at the LS (-0.8{\%} ± 0.2{\%} vs-0.4{\%} ± 0.2{\%}, P = 0.20) or FN (-0.8{\%} ± 0.3{\%} vs-0.6{\%} ± 0.3{\%}, P = 0.56) and remained similar after adjustment for age, weight, and BMD at index visit. Among HIV+ women, bone loss was associated with vitamin D deficiency and opiate use but not with use or class of antiretrovirals. Incidence of self-reported fracture was 0.74 per 100 person-years in HIV+ women and similar in HIV-women. Conclusions: In premenopausal HIV+ women, index BMD was lower than comparable HIV-women; however, rates of bone loss at the LS and FN were similar over 2.5 years of observation, irrespective of antiretroviral therapy.",
keywords = "Bone density, Bone loss, Bone turnover markers, HIV, Osteoporosis, Premenopausal women",
author = "Yin, {Michael T.} and Dalian Lu and Serge Cremers and Tien, {Phyllis C.} and Cohen, {Mardge H.} and Qiuhu Shi and Elizabeth Shane and Elizabeth Golub and Kathryn Anastos",
year = "2010",
month = "2",
doi = "10.1097/QAI.0b013e3181bf6471",
language = "English (US)",
volume = "53",
pages = "202--208",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Short-term bone loss in HIV-infected premenopausal women

AU - Yin, Michael T.

AU - Lu, Dalian

AU - Cremers, Serge

AU - Tien, Phyllis C.

AU - Cohen, Mardge H.

AU - Shi, Qiuhu

AU - Shane, Elizabeth

AU - Golub, Elizabeth

AU - Anastos, Kathryn

PY - 2010/2

Y1 - 2010/2

N2 - Background: Low bone mineral density (BMD) has been reported in HIV+ women, but less is known about the longitudinal evolution of BMD and fracture incidence. Methods: In 100 HIV+ and 68 HIV-premenopausal women in the Women's Interagency HIV Study, BMD was measured by dual energy X-ray absorptiometry at the femoral neck (FN) and lumbar spine (LS) at index visit and after a median of 2.5 years. Results: In HIV+ women, BMD at index visit was normal but 5% lower at the LS and FN than in HIV-women. Annual percent decrease in BMD did not differ between HIV+ and HIV-women at the LS (-0.8% ± 0.2% vs-0.4% ± 0.2%, P = 0.20) or FN (-0.8% ± 0.3% vs-0.6% ± 0.3%, P = 0.56) and remained similar after adjustment for age, weight, and BMD at index visit. Among HIV+ women, bone loss was associated with vitamin D deficiency and opiate use but not with use or class of antiretrovirals. Incidence of self-reported fracture was 0.74 per 100 person-years in HIV+ women and similar in HIV-women. Conclusions: In premenopausal HIV+ women, index BMD was lower than comparable HIV-women; however, rates of bone loss at the LS and FN were similar over 2.5 years of observation, irrespective of antiretroviral therapy.

AB - Background: Low bone mineral density (BMD) has been reported in HIV+ women, but less is known about the longitudinal evolution of BMD and fracture incidence. Methods: In 100 HIV+ and 68 HIV-premenopausal women in the Women's Interagency HIV Study, BMD was measured by dual energy X-ray absorptiometry at the femoral neck (FN) and lumbar spine (LS) at index visit and after a median of 2.5 years. Results: In HIV+ women, BMD at index visit was normal but 5% lower at the LS and FN than in HIV-women. Annual percent decrease in BMD did not differ between HIV+ and HIV-women at the LS (-0.8% ± 0.2% vs-0.4% ± 0.2%, P = 0.20) or FN (-0.8% ± 0.3% vs-0.6% ± 0.3%, P = 0.56) and remained similar after adjustment for age, weight, and BMD at index visit. Among HIV+ women, bone loss was associated with vitamin D deficiency and opiate use but not with use or class of antiretrovirals. Incidence of self-reported fracture was 0.74 per 100 person-years in HIV+ women and similar in HIV-women. Conclusions: In premenopausal HIV+ women, index BMD was lower than comparable HIV-women; however, rates of bone loss at the LS and FN were similar over 2.5 years of observation, irrespective of antiretroviral therapy.

KW - Bone density

KW - Bone loss

KW - Bone turnover markers

KW - HIV

KW - Osteoporosis

KW - Premenopausal women

UR - http://www.scopus.com/inward/record.url?scp=75649084530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75649084530&partnerID=8YFLogxK

U2 - 10.1097/QAI.0b013e3181bf6471

DO - 10.1097/QAI.0b013e3181bf6471

M3 - Article

VL - 53

SP - 202

EP - 208

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 2

ER -